Cytokinetics Inc. buy Wells Fargo & Company
Start price
10.04.26
/
50%
€55.40
Target price
10.04.27
€81.26
Performance (%)
25.42%
Price
09:32
€69.48
Summary
This prediction is currently active. The prediction currently has a performance of 25.42%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 8.488% | 8.488% |
| iShares Core DAX® | 0.563% | 0.440% |
| iShares Nasdaq 100 | -0.162% | 1.619% |
| iShares Nikkei 225® | 1.098% | 9.607% |
| iShares S&P 500 | 0.014% | 0.689% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat